Associate Professor, Urology, University of Michigan Medical School Medical Director, University of Michigan Comprehensive Cancer Center Ambulatory Care Unit
Urology
Dr. Alon Z. Weizer, MD
|
|
Give Review
Doctor Alon Z. Weizer, MD is an expert in the field of Urology. He graduated from Baylor College of Medicine. He over the years received 2 awards: "Regional Top Doctor" and "CMS Meaningful Use Stage 1 Certification". Alon Weizer has written publications. He has 92 publications published with PubMed. The lastest paper is: 'Independent Surgical Validation of the New Prostate Cancer Grade Grouping System.' He is registered with Medicare and accepts Medicare payments.
Publications
- Prognostic value of percent Gleason grade 4 at Prostate biopsy on predicting Prostatectomy pathology and recurrence.
- Patient Psoas Muscle Mass as a Predictor of Complications and Survival After Radical Cystectomy.
- Survivin is not an independent prognostic factor for patients with upper tract urothelial carcinoma: A multi-institutional study.
- Clinicopathologic characteristics of anterior prostate Cancer (APC), including correlation with previous biopsy pathology.
- Age, Gender and R.E.N.A.L. Nephrometry Score do not Improve the Accuracy of a Risk-Stratification Algorithm Based on Percutaneous Renal Mass Biopsy and Mass Size for A...
- Treatment Response Assessment for Bladder Cancer on CT Based on Computerized Volume Analysis, World Health Organization Criteria, and RECIST.
- Molecular and Immunohistochemical Characterization Reveals Novel BRAF Mutations in Metanephric Adenoma.
- The RAZOR (randomized open vs robotic cystectomy) trial: study design and trial update.
- Prostate capsule sparing versus nerve sparing radical cystectomy for Bladder cancer: results of a randomized, controlled trial.
- Tumor evolution and progression in multifocal and paired non-invasive/invasive urothelial carcinoma.
- Evaluation of the prognostic significance of altered Mammalian target of rapamycin pathway biomarkers in upper tract urothelial carcinoma.
- Multi-Institutional Validation of the Predictive Value of KI-67 in Patients with High-Grade Urothelial Carcinoma of the Upper Urinary Tract.
- Multicenter evaluation of the role of UroVysion FISH assay in surveillance of patients with Bladder cancer: does FISH positivity anticipate recurrence?
- HRAS mutations are frequent in inverted urothelial neoplasms.
- Understanding the Relationship Between Tumor Size, Gland Size, and Disease Aggressiveness in Men With Prostate Cancer.
- Technique and Outcomes of Robot-assisted Retroperitoneoscopic Partial Nephrectomy: A Multicenter Study.
- Long-term Renal functional outcomes ofminimally invasive partial nephrectomy for Renal cell carcinoma.
- Tumor Enucleation vs Sharp Excision in Minimally Invasive Partial Nephrectomy: Technical Benefit Without Impact on Functional or Oncologic Outcomes.
- Adherence to Performance Measures and Outcomes among Men Treated for Prostate Cancer.
- Long-Term Oncologic Outcomes of Minimally Invasive Partial Nephrectomy for Renal-Cell Carcinoma.
- Papillary Renal cell carcinoma revisited: a comprehensive histomorphologic study with outcome correlations.
- Primary Urethral Clear-Cell Adenocarcinoma: Comprehensive Analysis by Surgical Pathology, Cytopathology, and Next-Generation Sequencing.
- Sharpening the focus on causes and timing of readmission after radical cystectomy for Bladder cancer.
- Impact of distal ureter management on oncologic outcomes following radical nephroureterectomy for upper tract urothelial carcinoma.
- Complications associated with single-dose, perioperative mitomycin-C for patients undergoing Bladder tumor resection.
- The impact of technology diffusion on treatment for prostate Cancer.
- Matched Comparison of Robotic vs Laparoscopic Nephroureterectomy: An Initial Experience.
- Insulin-like Growth Factor Messenger RNA-binding Protein 3 Expression Helps Prognostication in Patients with Upper Tract Urothelial Carcinoma.
- Prediction of Intravesical Recurrence After Radical Nephroureterectomy: Development of a Clinical Decision-making Tool.
- A phase II trial of neoadjuvant nab-paclitaxel, carboplatin, and gemcitabine (ACaG) in patients with locally advanced carcinoma of the Bladder.
- Reply from Authors re: Manfred P. Wirth, Johannes Huber. What Really Matters Is Rarely Measured: Outcome of Routine Care and Patient-reported Outcomes. Eur Urol. In pr...
- Complications After Robot-assisted Radical Cystectomy: Results from the International Robotic Cystectomy Consortium.
- Technology diffusion and diagnostic testing for prostate Cancer.
- Quality indicators in the management of Bladder cancer.
- Impact of Renal function on eligibility for chemotherapy and survival in patients who have undergone radical nephro-ureterectomy.
- Evidence of perineural invasion on Prostate biopsy specimen and survival after radical Prostatectomy.
- Accuracy of determining small Renal mass management with risk stratified biopsies: confirmation by final pathology.
- Prediction of true nodal status in patients with pathological lymph node negative upper tract urothelial carcinoma at radical nephroureterectomy.
- Urethral Cancer.
- Association of Renal nephrometry score with outcomes of minimally invasive partial nephrectomy.
- Measures of impact: Diabetes and urothelial Cancer.
- Editorial Comment on END-2012-0170-TE.R1.
- A matched comparison of perioperative outcomes of a single laparoscopic surgeon versus a multisurgeon robot-assisted cohort for partial nephrectomy.
- Understanding criteria for surveillance of patients with a small Renal mass.
- Matched Comparison of Robotic-assisted and Open Radical Cystectomy.
- A Comparison of Extraperitoneal and Intraperitoneal Approaches for Robotic Prostatectomy.
- Disparities in Bladder cancer.
- Use of Restaging Bladder Tumor Resection for Bladder Cancer Among Medicare Beneficiaries.
- Metabolomic Profiling Reveals Potential Markers and Bioprocesses Altered in Bladder Cancer Progression.
- Complications of laparoscopic partial nephrectomy.
- Efficient delivery of radical cystectomy after neoadjuvant chemotherapy for muscle-invasive Bladder cancer: A multidisciplinary approach.
- Understanding Early Functional Recovery After Robotic Prostatectomy.
- Robot-assisted retroperitoneal partial nephrectomy: technique and perioperative results( * ).
- Editorial comment. Perioperative mortality is significantly greater in septuagenarian and octogenarian patients treated with radical cystectomy for urothelial carcinom...
- Does robotic technology mitigate the challenges of large Prostate size?
- T1 Bladder cancer: advocating early cystectomy to improve oncologic control.
- Is residual neurovascular tissue on Prostatectomy specimens associated with surgeon intent at nerve-sparing and postoperative quality of life measures?
- The role of lymphadenectomy in minimally invasive urologic oncology.
- Concomitant carcinoma in situ is a feature of aggressive Disease in patients with organ confined urothelial carcinoma following radical nephroureterectomy.
- Margin control in robotic and laparoscopic Prostatectomy: what are the REAL outcomes?
- Multiple adverse histological features increase the odds of under staging T1 Bladder cancer.
- Lidocaine patch for postoperative analgesia after radical retropubic Prostatectomy.
- MDCT Urography: Exploring a new paradigm for imaging of Bladder cancer.
- Development of a multiplex quantitative PCR signature to predict progression in non-muscle-invasive Bladder cancer.
- Outcomes of radical nephroureterectomy: a series from the Upper Tract Urothelial Carcinoma Collaboration.
- Understanding Bladder cancer death: tumor biology versus physician practice.
- Tailoring technique of laparoscopic partial nephrectomy to tumor characteristics.
- Understanding potential intraoperative impediments for learning laparoscopic nephrectomy.
- Understanding differences between high and low volume hospitals for radical Prostatectomy.
- The use of tumor markers in testis Cancer in the United States: a potential quality issue.
- Evaluation of the Prostate peripheral zone/capsule in patients undergoing radical cystoProstatectomy: defining risk with Prostate capsule sparing cystectomy.
- Progression of Disease despite good endoscopic local control of upper tract urothelial carcinoma.
- New concepts in shock wave lithotripsy.
- Adoption of new technology and healthcare quality: surgical margins after robotic Prostatectomy.
- Getting under the hood of the volume-outcome relationship for radical cystectomy.
- Measuring health-related quality of life outcomes in Bladder cancer patients using the Bladder Cancer Index (BCI).
- Performance status is a predictor of overall survival of elderly patients with muscle invasive Bladder cancer.
- Aggressive management of elderly patients with muscle-invasive Bladder cancer.
- Use of negative-pressure dressings and split-thickness skin grafts following Penile shaft reduction and reduction scrotoplasty in the management of penoscrotal elephan...
- Complications after percutaneous radiofrequency ablation of Renal tumors.
- Twenty-five years of shockwave lithotripsy: back to the future?
- Ureteroscopic management of renal calculi in anomalous Kidneys.
- PlasmaKinetic bipolar vessel sealing: burst pressures and thermal spread in an animal model.
- Cost comparison of radical retropubic and radical perineal Prostatectomy: single institution experience.
- Bilateral Renal calculi: assessment of staged v synchronous percutaneous nephrolithotomy.
- Urinary continence and quality of life in the first year after radical perineal Prostatectomy.
- Determining the incidence of horseshoe Kidney from radiographic data at a single institution.
- Prospective evaluation of pain medication requirements and recovery after radical perineal Prostatectomy.
- Percutaneous management of calculi within horseshoe Kidneys.
- A longitudinal assessment of bowel related symptoms and fecal incontinence following radical perineal Prostatectomy.
- Independent Surgical Validation of the New Prostate Cancer Grade Grouping System.
Schools
Baylor University
Procedures Preformed
- AdRenalectomy
- AdRenalectomy With Robotic Assistance
- Complete Nephrectomy With Robotic Assistance
- Cystectomy
- View All
Conditions Treated
- Balanoposthitis
- Bladder Cancer
- Bladder Infection
- Bladder Stones
- View All
Doctors Specialties
- Urology
Accepted Insurances
Awards
- Regional Top Doctor
- CMS Meaningful Use Stage 1 Certification
Education
-
Duke University Hospital -
Baylor College of Medicine
Hospital
-
University of Michigan Hospitals and Health Centers
Drug Facts
| NPI NUMBER | 1114019585 | |
| NPPES Provider LastName | WEIZER | |
| NPPES Provider FirstName | ALON | |
| NPPES Provider ZIPCode | 481095913 | |
| NPPES Provider State | MI | |
| Specialty Description | Urology | |
| Total Claim Count | 303.0 | |
| Distinct Opioid Count | 1.0 | |
| Opioid Claim Count | 17.0 | |
| Percent Opioid Claims | 5.61 |
Helpful Reviews
Medicare Facts
| National Provider Identifier [NPI] | 1114019585 |
| Last Name Of The Provider | WEIZER |
| First Name Of The Provider | ALON |
| View All |
Similar Doctors
|
|
Dr. James Q. Clemens, MD
 This Doctor is OpenDoctor Recommended.
|
|
Dr. John T. Wei, MD |
|
|
Dr. David C. Miller, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Anne K. Pelletier Cameron, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Robert H. Moyad, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Christopher P. Filson, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Alison M. Lake, MD |
|
|
Dr. Miriam Hadj-Moussa, MD |
|
|
Dr. Bruce L. Jacobs, MD |
|
|
Dr. Amy N. Luckenbaugh, MD |
|
|
Dr. Jaclyn C. Milose, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Daniel L. Miller, MD |
|
|
Dr. Sara M. Lenherr, MD
This Doctor is OpenDoctor Recommended.
|